Artificially-manipulated neovascularization regulatory system
US11999952B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Apr 21, 2021 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Dec 30, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an artificially manipulated neovascularization-associated factor for regulating neovascularization and a use thereof. More particularly, the present invention relates to a system for artificially regulating neovascularization, which includes an artificially manipulated neovascularization-associated factor for regulating neovascularization and/or a composition for artificially manipulating the neovascularization-associated factor. In a specific aspect, a neovascularization regulatory system including a neovascularization-associated factor such as artificially manipulated VEGFA, HIF1A, ANGPT2, EPAS1, or ANGPTL4 and/or an expression product thereof is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.